HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

rs4771122 Predicts Multiple Measures of Long-Term Weight Loss After Bariatric Surgery.

Abstract
We examined the association of 34 single nucleotide polymorphisms with weight loss up to 9.5 years after Roux-en-Y surgery. Participants were enrollees in the NUgene biobank with stored DNA and linked electronic health records. Ninety-five self-identified white participants underwent surgery and had follow-up weights obtained between 1 and 9.5 years after surgery. SNP rs4771122 was the variant most significantly associated with long-term weight loss after surgery in a repeated linear mixed model (p = .004) of long-term weight loss. In this model, each additional copy of the minor allele was associated with nearly 5 % greater percentage weight loss. This same SNP was also nominally significantly (p < .05) associated with weight loss trajectories, weight loss nadir, and weight loss 2 years after surgery.
AuthorsLaura J Rasmussen-Torvik, Abigail S Baldridge, Jennifer A Pacheco, Sharon A Aufox, Kwang-Youn A Kim, Jonathan C Silverstein, Erwin W Denham, Eric Hungness, Maureen E Smith, Philip Greenland
JournalObesity surgery (Obes Surg) Vol. 25 Issue 11 Pg. 2225-9 (Nov 2015) ISSN: 1708-0428 [Electronic] United States
PMID26337695 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Eukaryotic Initiation Factors
  • MTIF3 protein, human
  • Mitochondrial Proteins
Topics
  • Adult
  • Bariatric Surgery
  • Databases, Genetic
  • Eukaryotic Initiation Factors (genetics)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitochondrial Proteins (genetics)
  • Obesity, Morbid (genetics, surgery)
  • Polymorphism, Single Nucleotide
  • Weight Loss (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: